Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 13, 2002Proceedings of the National Academy of Sciences

A-317491, a novel potent and selective non-nucleotide antagonist of P2X 3 and P2X 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMichael F. JarvisQueensland University of TechnologyEBEdward C. BurgardDignify Therapeutics (United States)SMSteve McGaraughtyAbbVie (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jarvis et al. (2002) studied this question.

synapsesocial.com/papers/6a77d6172ea07b97ffae0c90https://doi.org/10.1073/pnas.252537299
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12′,3′‐O‐(2,4,6‐ trinitrophenyl) adenosine 5′‐triphosphate (TNP‐ATP)–a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels1998 · 91 citations
  2. 2In vivo pathway of thermal hyperalgesia by intrathecal administration of α,β‐methylene ATP in mouse spinal cord: Involvement of the glutamate‐NMDA receptor system1999 · 101 citations
  3. 3P2X Receptor–Mediated Ionic Currents in Dorsal Root Ganglion Neurons1999 · 161 citations